MACK Merrimack Pharmaceuticals, Inc. Stock Quote

MACK [NASD]

Index	-	P/E	-	EPS (ttm)	-0.14	Insider Own	1.09%	Shs Outstand	13.41M	Perf Week	4.95%
Market Cap	71.07M	Forward P/E	-	EPS next Y	-	Insider Trans	180.71%	Shs Float	13.26M	Perf Month	-4.93%
Income	-1.90M	PEG	-	EPS next Q	-	Inst Own	64.20%	Short Float	2.05%	Perf Quarter	-17.83%
Sales	-	P/S	-	EPS this Y	19.10%	Inst Trans	4.94%	Short Ratio	15.64	Perf Half Y	27.40%
Book/sh	1.05	P/B	5.05	EPS next Y	-	ROA	-12.50%	Target Price	4.00	Perf Year	-16.54%
Cash/sh	1.07	P/C	4.97	EPS next 5Y	5.60%	ROE	-13.00%	52W Range	3.66 - 7.41	Perf YTD	35.55%
Dividend	-	P/FCF	-	EPS past 5Y	56.90%	ROI	-	52W High	-28.48%	Beta	1.67
Dividend %	-	Quick Ratio	25.90	Sales past 5Y	-	Gross Margin	-	52W Low	44.81%	ATR	0.34
Employees	-	Current Ratio	25.90	Sales Q/Q	-	Oper. Margin	-	RSI (14)	46.11	Volatility	8.20% 5.84%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	81.10%	Profit Margin	-	Rel Volume	0.08	Prev Close	5.13
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	-	Avg Volume	17.36K	Price	5.30
Recom	3.50	SMA20	-0.94%	SMA50	-10.01%	SMA200	4.91%	Volume	1,472	Change	3.31%

Oct-07-16

Downgrade

JP Morgan

Overweight → Neutral

May-27-16

Initiated

Robert W. Baird

Neutral

Dec-23-15

Reiterated

Mizuho

Buy

$16 → $13

Oct-27-15

Reiterated

Oppenheimer

Outperform

$13 → $15

Apr-21-15

Reiterated

Mizuho

Buy

$13 → $16

Oct-10-14

Resumed

Oppenheimer

Outperform

$9 → $11

Jul-08-14

Resumed

Brean Capital

Buy

$16

Jun-20-14

Reiterated

Oppenheimer

Outperform

$10 → $8.50

Aug-09-13

Reiterated

Oppenheimer

Outperform

$12 → $10

Jun-25-13

Initiated

Mizuho

Buy

$12

May-08-12

Initiated

Oppenheimer

Outperform

$12

May-05-22 04:30PM	Merrimack Reports First Quarter 2022 Financial Results Business Wire
Mar-09-22 04:30PM	Merrimack Reports Full Year 2021 Financial Results Business Wire +5.49%
Jan-27-22 04:48AM	Insider Buying: The Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Co-Founder & Independent Director Just Bought 63% More Shares Simply Wall St. -5.34%
Dec-06-21 07:22AM	Here's Why We're Not At All Concerned With Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn Situation Simply Wall St.
Nov-04-21 05:00PM	Merrimack Reports Third Quarter 2021 Financial Results Business Wire
Sep-06-21 09:50AM	A Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insider increased their holdings by 43% last year Simply Wall St.
Aug-05-21 04:30PM	Merrimack Reports Second Quarter 2021 Financial Results Business Wire
Jun-08-21 05:31AM	Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Can Afford To Invest In Growth Simply Wall St.
Jun-07-21 02:10PM	Elevation Oncology Files for $100M IPO Benzinga
May-28-21 08:00AM	180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors GlobeNewswire
Mar-10-21 06:00PM	Merrimack Reports Full Year 2020 Financial Results Business Wire
Dec-10-20 02:10AM	How Much Of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Do Institutions Own? Simply Wall St.
Dec-03-20 07:46AM	The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut Benzinga -6.01%
Nov-29-20 12:12PM	Where Do Hedge Funds Stand On Merrimack Pharmaceuticals Inc (MACK)? Insider Monkey
Nov-05-20 08:20AM	Merrimack Reports Third Quarter 2020 Financial Results Business Wire
Aug-07-20 08:20AM	Merrimack Reports Second Quarter 2020 Financial Results Business Wire
Aug-05-20 08:33AM	We Think Merrimack Pharmaceuticals (NASDAQ:MACK) Needs To Drive Business Growth Carefully Simply Wall St.
May-07-20 06:10PM	Merrimack Reports First Quarter 2020 Financial Results Business Wire
Apr-02-20 08:30AM	Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update Business Wire +8.60%
Feb-07-20 11:14AM	What Kind Of Share Price Volatility Should You Expect For Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)? Simply Wall St.
Dec-22-19 07:44PM	Hedge Funds Are Selling Merrimack Pharmaceuticals Inc (MACK) Insider Monkey
Dec-03-19 09:15AM	Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan Business Wire +9.87%
08:45AM	Merrimack Receives $5 Million Milestone Payment from Ipsen; Declares $6.7 Million Special Dividend Business Wire
Oct-28-19 06:04AM	Proxy fights reach 'frightening' level in life sciences, other industries, top attorney says American City Business Journals
Sep-24-19 04:45PM	JFL Capital Ends Campaign at Merrimack PR Newswire
Sep-19-19 03:23PM	Should You Buy Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) For This Reason? Simply Wall St.
09:00AM	Merrimack Pharmaceuticals Announces Changes to Board of Directors Business Wire
Aug-26-19 11:27AM	Texas investor group fighting for control of crumbling Merrimack Pharmaceuticals American City Business Journals
09:00AM	Merrimack Pharmaceuticals Issues Letter to Shareholders Business Wire
Aug-22-19 08:30AM	JFL Capital Issues Letter to Fellow Merrimack Stockholders PR Newswire
Aug-16-19 09:15AM	Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting of Shareholders for October 17, 2019 Business Wire
Jul-25-19 08:30AM	Merrimack Declares $20 Million Special Dividend PR Newswire
May-31-19 07:34AM	The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering Benzinga
06:21AM	Merrimack axes remaining staff, execs after selling assets to New York startup American City Business Journals
May-30-19 04:05PM	Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend PR Newswire
May-10-19 07:30AM	Merrimack Reports First Quarter 2019 Financial Results PR Newswire
May-06-19 01:46PM	COMM 2014-UBS2 Mortgage Trust -- Moody's affirms ten classes of COMM 2014-UBS2 Moody's
May-03-19 05:43PM	COMM 2014-UBS2 Mortgage Trust -- Moody's affirms ten classes of COMM 2014-UBS2 Moody's
Apr-18-19 03:07PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK GlobeNewswire
Apr-16-19 04:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK ACCESSWIRE
Apr-12-19 01:57PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK GlobeNewswire
Apr-09-19 05:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK PR Newswire
Apr-08-19 10:12AM	Merrimack Pharmaceuticals, Inc. (MACK) - Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ACCESSWIRE
Apr-05-19 08:29AM	The Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Is Down 92% So Some Shareholders Are Rather Upset Simply Wall St.
07:48AM	The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership Benzinga
Apr-04-19 05:58PM	Merrimack shelves another cancer drug, plans more layoffs American City Business Journals
04:15PM	Merrimack Discontinues Development of MM-310 PR Newswire
Mar-07-19 09:06AM	Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4 Zacks
Mar-06-19 07:00AM	Merrimack Reports Fourth Quarter and Full Year 2018 Financial Results PR Newswire
Feb-12-19 07:35AM	New Research: Key Drivers of Growth for ON Semiconductor, Entegris, Universal, MarineMax, Epizyme, and Merrimack Pharmaceuticals Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-11-19 09:39AM	Merrimack (MACK) Stock Up Year to Date: Is a Rebound Likely? Zacks
Jan-28-19 10:19PM	Edited Transcript of MACK earnings conference call or presentation 7-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Dec-10-18 05:00PM	John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman GlobeNewswire
Nov-09-18 10:31AM	Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q3 Zacks
08:45AM	Research Report Identifies Merrimack Pharmaceuticals, PNM Resources, Inc. (Holding Co.), Carrols Restaurant Group, American Axle & Manufacturing, CBIZ, and Nova Measuring Instruments with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-08-18 10:17AM	Merrimack to shelve lead cancer drug, lay off most of workforce American City Business Journals
Nov-07-18 06:45AM	Merrimack Reports Third Quarter 2018 Financial Results and Provides Strategic Update Following Portfolio Review PR Newswire
Nov-06-18 01:44PM	Merrimack Pharmaceuticals Q3 Earnings Preview Benzinga
Nov-05-18 07:55AM	5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings Zacks
Oct-31-18 04:05PM	Merrimack Announces Timing of Third Quarter 2018 Investor Conference Call PR Newswire
Oct-24-18 11:19AM	Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod Zacks
Oct-19-18 10:48AM	Merrimack's String of Failures Continues With Lung Cancer Study Shelved After Midstage Trials Benzinga
07:46AM	Merrimack Pharmaceuticals' stock plummets toward record low after cancer drug trial terminated MarketWatch
06:00AM	Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility PR Newswire
Oct-16-18 07:30AM	Detailed Research: Economic Perspectives on Clearside Biomedical, JELD-WEN Holding, L.B. Foster, Merrimack Pharmaceuticals, Everi, and Drive Shack What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-11-18 05:16PM	Merrimack (MACK) Focuses on Early Stage Pipeline and Cost Cuts Zacks
Sep-20-18 07:00AM	Merrimack Receives $5 Million Milestone Payment from Shire PR Newswire
Sep-06-18 10:35AM	Merrimack (MACK) Up 6.7% Since Last Earnings Report: Can It Continue? Zacks
06:50AM	Merrimack Completes Enrollment in Randomized Phase 2 SHERLOC Study of MM-121 (seribantumab) in Non-Small Cell Lung Cancer (NSCLC) PR Newswire
Sep-05-18 12:06PM	Edited Transcript of MACK earnings conference call or presentation 7-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Sep-04-18 10:07AM	Zacks.com highlights: American Woodmark, Adverum Biotechnologies, Merrimack Pharmaceuticals, Athene Holding and M&T Bank Zacks
Aug-16-18 08:00AM	Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus, Merrimack Pharmaceuticals, La Jolla Pharmaceutical, and SPX New Research Emphasizes Economic Growth GlobeNewswire
Aug-08-18 10:20AM	Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q2 Zacks
Aug-07-18 08:18AM	Merrimack (MACK) Reports Wider-than-Expected Q2 Loss Zacks
06:30AM	Merrimack Reports Second Quarter 2018 Financial Results PR Newswire
06:30AM	Merrimack Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 12:09PM	Is a Beat in the Cards for Merrimack (MACK) in Q2 Earnings? Zacks
Jul-31-18 04:10PM	Merrimack Announces Timing of Second Quarter 2018 Investor Conference Call PR Newswire
Jul-10-18 04:55PM	Ex-biopharmaceutical employees convicted in U.S. of insider trading Reuters
Jul-02-18 04:15PM	Merrimack Secures $25 Million Debt Facility with Hercules Capital PR Newswire
Jun-27-18 08:12AM	Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod Zacks
Jun-26-18 07:51PM	Ex-Akebia employee jailed for night as insider trading trial starts Reuters
08:12AM	Merrimack Crashes as Phase II Pancreatic Cancer Study Fails Zacks
Jun-25-18 07:55AM	Merrimack to scrap development of pancreatic cancer treatment Reuters
07:54AM	UPDATE: Merrimack Pharma shares slide 34% after trial of pancreatic cancer treatment fails to meet main goals MarketWatch
07:29AM	Merrimack to scrap development of pancreatic cancer treatment Reuters
07:20AM	Merrimack Announces Top-Line Results from Randomized Phase 2 Trial of MM-141 in Front-Line Metastatic Pancreatic Cancer PR Newswire
Jun-15-18 08:41AM	Options Traders Expect Huge Moves in Merrimack Pharmaceuticals (MACK) Stock Zacks
Jun-07-18 09:15AM	Why is Merrimack (MACK) Up 6.3% Since Its Last Earnings Report? Zacks
Jun-04-18 01:57PM	Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-29-18 08:15AM	Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
07:00AM	Merrimack to Present at the 2018 American Society of Clinical Oncology Annual Meeting PR Newswire
May-09-18 10:49AM	Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 Zacks
May-08-18 06:25AM	Merrimack Reports First Quarter 2018 Financial Results PR Newswire
May-03-18 10:13AM	What's in the Cards for Merrimack (MACK) in Q1 Earnings? Zacks
May-01-18 07:00AM	Merrimack Announces Timing of First Quarter 2018 Investor Conference Call PR Newswire
Apr-09-18 07:30AM	Merrimack to Present Preclinical Data at the 2018 American Association for Cancer Research Annual Meeting PR Newswire
Apr-04-18 08:15AM	Consolidated Research: 2018 Summary Expectations for Merrimack Pharmaceuticals, Monroe Capital, NL Industries, FCB Financial, Amtech, and Otter Tail Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-14-18 07:30AM	Wired News Merrimack Expanded Enrollment in Ongoing Randomized Phase-2 SHERLOC Trial of MM-121 in Non-Small Cell Lung Cancer ACCESSWIRE
Mar-13-18 09:45AM	Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4 Zacks

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CROCKER GARY L	See Remarks	May 19	Buy	5.04	512	2,582	123,549	May 23 04:05 PM
CROCKER GARY L	See Remarks	May 18	Buy	5.08	5,000	25,407	123,037	May 19 04:05 PM
CROCKER GARY L	See Remarks	May 17	Buy	5.10	225	1,147	118,037	May 19 04:05 PM
CROCKER GARY L	See Remarks	Apr 21	Buy	6.00	5,000	30,001	115,338	Apr 25 04:05 PM
CROCKER GARY L	See Remarks	Mar 31	Buy	6.18	300	1,853	110,338	Apr 01 04:05 PM
CROCKER GARY L	See Remarks	Mar 30	Buy	6.20	161	998	110,038	Apr 01 04:05 PM
CROCKER GARY L	See Remarks	Mar 28	Buy	6.16	5,000	30,822	109,877	Mar 29 05:30 PM
CROCKER GARY L	See Remarks	Mar 22	Buy	6.11	400	2,446	104,877	Mar 24 04:05 PM
CROCKER GARY L	See Remarks	Mar 15	Buy	6.14	4,649	28,556	104,477	Mar 17 04:05 PM
CROCKER GARY L	See Remarks	Mar 14	Buy	6.02	5,000	30,120	99,828	Mar 15 04:05 PM
CROCKER GARY L	See Remarks	Mar 11	Buy	6.08	5,000	30,406	94,828	Mar 15 04:05 PM
CROCKER GARY L	See Remarks	Feb 18	Buy	5.96	3,351	19,970	89,828	Feb 23 04:05 PM
CROCKER GARY L	See Remarks	Feb 17	Buy	6.13	5,000	30,626	86,477	Feb 18 04:05 PM
CROCKER GARY L	See Remarks	Feb 16	Buy	6.20	7,945	49,231	81,477	Feb 18 04:05 PM
CROCKER GARY L	See Remarks	Feb 15	Buy	6.20	123	763	73,532	Feb 16 04:05 PM
CROCKER GARY L	See Remarks	Feb 14	Buy	5.96	1,800	10,724	73,409	Feb 16 04:05 PM
Levy Noah G.	Director	Jan 31	Buy	5.05	1,237	6,246	989,337	Feb 01 04:05 PM
Levy Noah G.	Director	Jan 28	Buy	4.48	12,963	58,033	988,623	Feb 01 04:05 PM
Levy Noah G.	Director	Jan 27	Buy	4.82	16,272	78,475	712,294	Jan 28 04:05 PM
CROCKER GARY L	See Remarks	Jan 27	Buy	4.60	673	3,096	71,609	Jan 31 04:05 PM
CROCKER GARY L	See Remarks	Jan 26	Buy	4.56	3,100	14,121	70,936	Jan 27 04:05 PM
Levy Noah G.	Director	Jan 26	Buy	5.01	19,528	97,785	696,022	Jan 28 04:05 PM
Nielsen Ulrik B.	Director	Jan 24	Buy	4.24	14,287	60,630	36,968	Jan 25 04:13 PM
CROCKER GARY L	See Remarks	Jan 24	Buy	4.33	7,105	30,741	67,836	Jan 25 04:05 PM
CROCKER GARY L	See Remarks	Jan 21	Buy	4.65	2,000	9,310	60,731	Jan 25 04:05 PM
CROCKER GARY L	See Remarks	Jan 18	Buy	4.54	5,000	22,689	58,731	Jan 20 04:05 PM
CROCKER GARY L	See Remarks	Jan 14	Buy	4.51	5,000	22,554	53,731	Jan 18 04:05 PM
CROCKER GARY L	See Remarks	Jan 13	Buy	4.42	5,000	22,120	48,731	Jan 18 04:05 PM
CROCKER GARY L	See Remarks	Jan 12	Buy	4.33	5,000	21,658	43,731	Jan 13 04:05 PM
CROCKER GARY L	See Remarks	Jan 11	Buy	4.03	5,000	20,140	38,731	Jan 13 04:05 PM
Levy Noah G.	Director	Jan 11	Buy	4.00	91,270	364,907	987,118	Jan 12 04:05 PM
Levy Noah G.	Director	Jan 10	Buy	3.83	14,679	56,285	910,576	Jan 12 04:05 PM
Levy Noah G.	Director	Jan 07	Buy	3.82	8,780	33,524	901,857	Jan 10 04:05 PM
RAY RUSSELL T	Director	Dec 31	Sale	3.84	1,000	3,840	0	Jan 04 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience